#United States #Stockholders #Annual Meeting #Newport Beach #GABA Therapeutics

GABA Therapeutics Inc. Announces 2026 Annual Meeting of Stockholders

GABA Therapeutics Inc., based in Delaware, is set to hold its Annual Meeting of Stockholders on September 10, 2026. This meeting will take place at 9:30 a.m. Pacific Time and will be hosted at their offices located at 5000 Birch Street, West Tower, Suite 3000, Newport Beach, CA 92660.

Purpose of the Meeting

The primary agenda for the Annual Meeting includes the election of directors who will serve until their terms expire or until their successors are chosen. Additionally, other business matters may be discussed if they arise, ensuring shareholders have a platform to voice their interests and concerns.

Eligibility to Vote

It is important to note that only those stockholders who are registered as of the close of business on August 31, 2026, will have the right to vote. Eligible stockholders are defined as those who meet the criteria set forth in the Voting Agreement and are noted as 'Eligible Stockholders' under the amendments of the Omnibus Amendment. This emphasizes the company's commitment to corporate governance and transparency.

Access to Voting Information

In preparation for the voting process, GABA Therapeutics will make a comprehensive list of stockholders eligible to vote available for at least ten days leading up to the Annual Meeting. Stockholders will have access to this list during normal business hours at the company’s executive offices. This accessibility helps to facilitate informed participation by all eligible members.

Importance of Participation

Richard G. Farrell, the company’s Secretary and Chief Financial Officer, underscores that participating in the Annual Meeting is crucial for stockholders. Whether attending in person or remotely through video conference or phone, he urges all stockholders to exercise their right to vote on critical company matters. The governance structure of GABA Therapeutics allows stockholders to guide the future direction of the company through their voting actions.

In summary, the Annual Meeting serves as an essential opportunity for stockholders to engage with the company's future leadership and direction. With a focus on transparency, engagement, and governance, the 2026 Annual Stockholder Meeting is positioned to shape the future of GABA Therapeutics Inc. Stay informed and make your voice heard by participating in this vital event!